Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 7/2008

01-07-2008 | Original Article

Early decision and psychosocial support intervention for men with localised prostate cancer: an integrated approach

Authors: Suzanne K. Steginga, Megan Ferguson, Samantha Clutton, R. A. (Frank) Gardiner, David Nicol

Published in: Supportive Care in Cancer | Issue 7/2008

Login to get access

Abstract

Goal

Men diagnosed with prostate cancer experience high decision-related distress concurrent with cancer-related distress. Psycho-education, problem solving and decision support were integrated in a novel telephone-delivered supportive care intervention targeting men at diagnosis and assessed for feasibility.

Materials and Methods

An exploratory single-group pre–post-test design tracked session frequency, duration and content. Standardised measures assessed decisional conflict, cancer-related distress and decision involvement. Brief screening measures for psychological and decision-related distress were incorporated into the intervention protocol. Twenty men (77% response) newly diagnosed with localised prostate cancer received the intervention.

Results

Men who were undecided about treatment at study entry required more pre-treatment intervention calls (p < 0.013). Pre-treatment support calls were longer (M = 40.2 min) and more complex by comparison to post-treatment calls (M = 30.9 min; p < 0.002). Brief screening for decision-related distress correlated with concurrent (p < 0.008) and prospective (p < 0.046) decisional conflict. Decisional conflict and intrusion decreased at post-test (p < 0.001; p < 0.005). Men reported a high level of satisfaction with the support received with benefits identified including anonymity and accessibility.

Conclusions

In this setting, a tele-based supportive care and decision support intervention for men newly diagnosed with prostate cancer was feasible. The use of brief screening measures as within-intervention clinical tools appears promising.
Literature
1.
Ashton WA, Fuehrer A (1993) Effects of gender and gender role identification of participant and type of social resource on support seeking. Sex Roles 28:461–476CrossRef
2.
Australian Cancer Network Working Party on Management of Localised Prostate Cancer (2002) Clinical Practice Guidelines: Evidence-based information and recommendations for the management of localised prostate cancer. National Health and Medical Research Council, Canberra, Australia, pp 1-137
3.
Australian Institute of Health and Welfare, Australasian Association of Cancer Registries (2004) Cancer in Australia 2001. AIHW cat. no. CAN 23. Australian Institute of Health and Welfare, Australasian Association of Cancer Registries, Canberra, Australia
4.
Broadstock MJ, Hill D (1997) Evaluation and impact of promotion of a cancer helpline to cancer patients through their specialists. Patient Educ Couns 32:141–146PubMedCrossRef
5.
6.
Carlson LE, Bultz BD (2003) Cancer distress screening: Needs, models, and methods. J Psychosom Res 55:403–409PubMedCrossRef
7.
Clinical Oncological Society of Australia, The Cancer Council Australia, National Cancer Control Initiative (2003) Optimising Cancer Care in Australia. National Cancer Control Initiative, Melbourne, Australia, pp 122
8.
Collie K, Kreshka MA, Ferrier S, Parsons R, Graddy K, Avram S, Mannell P, Chen X, Perkins JJ, Koopman C (2007) Videoconferencing for delivery of breast cancer support groups living in rural communities: A pilot study. Psychooncology 16:778–782PubMedCrossRef
9.
Creamer M, Bell R, Failla S (2003) Psychometric properties of the Impact of Event Scale - Revised. Behav Res Ther 41:1489–1496PubMedCrossRef
10.
Davison BJ, Degner LF (1997) Empowerment of men newly diagnosed with prostate cancer. Cancer Nurs 20:187–196PubMedCrossRef
11.
Davison BJ, Degner LF, Morgan TR (1995) Information and decision-making preferences of men with prostate cancer. Oncol Nurs Forum 22:1404–1408
12.
Davison BJ, Gleave ME, Goldenberg SL, Degner LF, Hoffart D, Berkowitz J (2002) Assessing information and decision preferences of men with prostate cancer and their partners. Cancer Nurs 25:42–49PubMedCrossRef
13.
Davison BJ, Goldenberg SL, Gleave ME, Degner LF (2003) Provision of individualized information to men and their partners to facilitate decision making in prostate cancer. Oncol Nurs Forum 30:107–114PubMedCrossRef
14.
Evans R, Elwyn G, Edwards A, Watson E, Austoker J, Grol R (2007) Toward a model for field testing patient decision support technologies: A qualitative field testing study. J Internet Res 9:e21CrossRef
15.
Gielser RB, Given B, Given CW, Rawl S, Monahan P, Burns D, Azzouz F, Reuille KM, Weinrich S, Koch M, Champion V (2005) Improving the quality of life of patients with prostate cancer. Cancer 104:752–762CrossRef
16.
17.
Horowitz M, Wilner N, Alvarez W (1979) Impact of events scale: A measure of subjective stress. Psychosom Med 41:209–218PubMed
18.
Hu JC, Kwan L, Saigal CS, Litwin MS (2003) Regret in men treated for localised prostate cancer. J Urol 169:2279–2283PubMedCrossRef
19.
Hutchison S, Steginga SK, Dunn J (2006) The tiered model of psychosocial intervention in cancer: a community based approach. Psychooncology 15:541–546PubMedCrossRef
20.
Kessler L, Fintor L, Muha C, Wun L, Annett D, Mazan KD (1993) The Cancer Information Service Telephone Evaluation and Reporting System (CISTERS): A new tool for assessing quality assurance. J Nat Cancer Inst Monogr 14:61–65
21.
Lechner L, De Vries H (1996) The Dutch cancer information helpline: experience and impact. Patient Educ Couns 28:149–157PubMedCrossRef
22.
Lepore SJ, Helgeson VS, Eton DT, Schulz R (2003) Improving quality of life in men with prostate cancer: A randomized controlled trial of group education interventions. Health Psychol 22:443–452PubMedCrossRef
23.
Marcus A, Garrett KM, Kuluchak-Rahm A, Barnes D, Dortch W, Juno S (2002) Telephone counseling in psychosocial oncology: a report from the Cancer Information and Counseling Line. Patient Educ Couns 46:267–275PubMedCrossRef
24.
McVea KLSP, Minier WC, Johnson Palensky JE (2001) Low-income women with early stage breast cancer: Physician and patient decision making styles. Psychooncology 10:137–146PubMedCrossRef
25.
Mishel MH, Belyea M, Germino BB, Stewart JL, Bailey DE, Robertson C, Mohler J (2002) Helping patients with localized prostate cancer manage uncertainty and treatment side effects: nurse delivered psycho-education intervention over the telephone. Cancer 94:1854–1866PubMedCrossRef
26.
27.
National Comprehensive Cancer Network Inc. (2002) Practice Guidelines in Oncology-v.1.2002: Distress Management (Rep. No. Version 1). National Comprehensive Network
28.
O’Connor A, Fiset V, DeGrasse C, Graham ID, Evans W, Stacey D, Laupacis A, Tugwell P (1999) Decision aids for patients considering options affecting cancer outcomes: Evidence of efficacy and policy implications. J Nat Cancer Inst Monogr 25:67–80
29.
O’Connor A, Stacey D, Entwistle V, Llewellyn-Thomas H, Rovner D, Holmes-Rovner M, Barry M, Jones J (2004) Decision aids for people facing health treatment or screening decisions (Cochrane Review). The Cochrane Library. Wiley, UK
30.
31.
O’Connor AM, Rostom A, Fiset V, Tetroe J, Entwistle V, Llewellyn-Thomas H, Holmes-Rovner M, Barry M, Jones J (1999) Decision aids for patients facing health treatment or screening decisions: systematic review. Br Med J 319:731–734
32.
O’Connor A (2004) The Ottawa Personal Health Decision Guide. Ottawa Health Research Institute, Ottawa
33.
Occhipinti S, Steginga SK (Under review following revision) The relationship between optimism, coping appraisals, and psychosocial outcomes in men receiving treatment for localized prostate cancer. Health Psychol
34.
Parker C, Muston D, Moss S, Dearnaley D (2006) A model of the natural history of screen-detected prostate cancer and the effect of radical treatment on overall survival. Br J Cancer 94:1361–1368PubMedCrossRef
35.
Penedo FJ, Dahn JR, Molton I, Gonzalez JS, Kinsinger D, Roos BA, Carver CS, Schneiderman N, Antoni MH (2003) Cognitive-behavioral stress management improves stress-management skills and quality of life in men recovering from treatment of prostate carcinoma. Cancer 100:192–200CrossRef
36.
Ransom S, Jacobsen PB, Booth-Jones M (2006) Validation of the distress thermometer with bone marrow transplant patients. Psychooncology 15:604–612PubMedCrossRef
37.
Rickwood DJ, Braithwaite VA (1994) Social-psychological factors affecting help-seeking for emotional problems. Soc Sci Med 39:563–572PubMedCrossRef
38.
Simon GE, Ludman EJ, Tutty S, Operalski B, Von Korff M (2004) Telephone psychotherapy and telephone care managment for primary care patients starting anti depressant treatment: A Randomised Controlled Trial. J Am Med Assoc 292:935–942CrossRef
39.
Steginga SK, Occhipinti S (2004) The application of the Heuristic Systematic Processing Model to treatment decision making about prostate cancer. Med Decis Making 24:573–583PubMedCrossRef
40.
Steginga SK, Occhipinti S (2006) Dispositional optimism as a predictor of men’s decision-related distress after localized prostate cancer. Health Psychol 25:135–143PubMedCrossRef
41.
Steginga SK, Occhipinti S, Gardiner RA, Yaxley J, Heathcote P (2004) A prospective study of men’s psychological and decision-related adjustment after treatment for localized prostate cancer. Urology 63:751–756PubMedCrossRef
42.
Thompson SC, Pitts JS, Schwankovsky L (1993) Preferences for involvement in medical decision-making: Situational and demographic influences. Patient Educ Couns 22:133–140PubMedCrossRef
43.
Twomey C (2000) Telephone contacts with a cancer nurse specialist. Nurs Stand 15:35–38PubMed
44.
Walsh Scura K, Budin W, Garfing E (2004) Telephone social support and education for adaptation to prostate cancer: A pilot study. Oncol Nurs Forum 31:335–338CrossRef
45.
Weiss DS, Marmar CR (1997) The Impact of Events Scale - Revised. In: Wilson JP, Keane TM (eds) Assessing Psychological Trauma and PTSD. Guildford, New York, pp 399–411
Metadata
Title
Early decision and psychosocial support intervention for men with localised prostate cancer: an integrated approach
Authors
Suzanne K. Steginga
Megan Ferguson
Samantha Clutton
R. A. (Frank) Gardiner
David Nicol
Publication date
01-07-2008
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 7/2008
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-007-0351-7

Other articles of this Issue 7/2008

Supportive Care in Cancer 7/2008 Go to the issue

Original Article

Dying cancer patients’ experiences of powerlessness and helplessness

Supportive Care International

Herbal use among cancer patients during palliative or curative chemotherapy treatment in Norway

Review Article

Prophylaxis of catheter-related venous thrombosis in cancer patients

Original Article

Self-reported experience and outcomes of care among stomach cancer patients at a median follow-up time of 27 months from diagnosis

Erratum

Dying cancer patients’ experiences of powerlessness and helplessness

Original Article

Prophylactic anti-coagulation in cancer palliative care: a prospective randomised study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits